Relationship Apical Periodontitis and the Main Bacterial Species in the Oral Microbiota
Relationship of MMP-9 With the Clinical Course of Apical Periodontitis and the Main Bacterial Species in the Oral Microbiota
1 other identifier
interventional
60
1 country
1
Brief Summary
Aim: Apical periodontitis(AP) caused by root canal infection is the most frequent pathological lesion in the jaws. Bacterial products, host immune cells and biologically active factors called locally produced cytokines(such as IL-1, TNF-α) have been reported to play an important role in the pathogenesis of AP. Metalloproteinases(MMP), is a measurable biomarker that plays an important role in the degradation and regeneration of collagen and is an indicator of collagen. This study aimed to determine the main bacterial species in the microbiota as Gr(+) and Gr(-) and to compare the relationship between MMP-9 and TNF-α with controlled patient groups. Methodology:60 patients with AP and extraction indication were included in the study. 30 systemically and orally healthy volunteers were selected as the control group. After access cavity preparation, an initial microbiologic sample(S1) was taken from the root canal. After atraumatic extraction of the tooth, second microbial sample(S2) was taken from the external root surface. After bacterial DNA extraction, 16S rRNA gene primer was designed for sequence analysis. Bacterial community profiling was made by Sanger sequencing of the PCR products. Besides, blood samples were collected from all of the patients. Enzyme-linked immunosorbent assay was used to measure levels of MMP-9 and TNF-α.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2023
CompletedFirst Submitted
Initial submission to the registry
April 26, 2023
CompletedFirst Posted
Study publicly available on registry
May 12, 2023
CompletedMay 12, 2023
May 1, 2023
1 year
April 26, 2023
May 4, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Laboratory Analysis
Blood samples were collected from the patients for MMP-9 and TNF-α analysis. The blood samples taken from the patients in a tube with a gel separator were kept at room temperature for 20-30 minutes to coagulate, and then centrifuged at 1800 g for 10 minutes. T
The study was conducted between March 2022 and February 2023
Secondary Outcomes (2)
Bacteriological Sampling from the Root Canal System and Outer Root Surface
The study was conducted between March 2022 and February 2023
ELISA measurement procedure of MMP-9 and TNF-α levels
The study was conducted between March 2022 and February 2023
Study Arms (2)
apical periodontitis
EXPERIMENTAL60 patients with AP and extraction indication (due to restorative causes and lesion size) were included in the study
control
EXPERIMENTALA total of 30 volunteers who were determined to be systemically and orally healthy (not having AP indication), were included in the study as the control group.
Interventions
Of these patients, 60 patients with AP and extraction indication (due to restorative causes and lesion size) were included in the study
Eligibility Criteria
You may qualify if:
- AP and extraction indication (due to restorative causes and lesion size) were included in the study
You may not qualify if:
- Patients who had any acute or chronic inflammatory disease, known infection status, history of trauma or surgical operation within 6 months that may affect MMP-9 levels, pregnant and/or lactating, malignity, morbid obesity, arthritis, immunologic diseases, cardiovascular diseases or use of vitamins with high biotin were not included in the study. Additionally, patients who used antibiotics or anti-inflammatory drugs within the last 6 months, and patients with periodontal disease were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Medipol University, Faculty of Dentistry
Istanbul, Esenler, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seyda Ersahan, Assoc.Prof.
IstanbulMedipol University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 26, 2023
First Posted
May 12, 2023
Study Start
November 15, 2021
Primary Completion
November 15, 2022
Study Completion
February 15, 2023
Last Updated
May 12, 2023
Record last verified: 2023-05